Icotinib and rh-endostatin as first line therapy in advanced non small cell line cancer patients harboring activating epidermal growth factor receptor mutations
Zhao, Qiong, Peng, Ling, Chen, Feng, Hong, Zhihai, Mou, Haibo, Wang, Yina, Tang, Yemin, Liu, Junfang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article